CHI's flagship biologics event will return to Boston's trendy Seaport District April 25-29, 2016.
With record-breaking attendance in 2015, PEGS Boston attracts an international delegation of nearly 2,000 participants including conference delegates, speakers, exhibitors, sponsors and guests representing over 30 countries.
Participants value the in-depth short courses, access to 22 conferences, and wide-ranging presentations delivering new unpublished data, case studies, innovation and insight.
The vast exhibit hall will be packed with 125 exhibiting companies and more than 200 research posters on display providing valuable viewing of innovative new technologies, as well as abundant networking with biopharma researchers and industry representatives.
Reserve your spot at PEGS Boston 2016 to:
PLENARY KEYNOTE SPEAKERS
Antibody Therapeutics: Past, Present and Future
Paul J. Carter, Ph. D., Senior Director and Staff Scientist, Antibody Engineering, Genentech, Inc.
Talk Title to be Announced
Deborah Law, Ph.D., CSO, Jounce Therapeutics